-
Introduction
-
How to Claim Continuing Education
- Friday, 4/12 - Welcome
-
Welcome Remarks 12 min
-
Patient Advocacy Keynote: Survival of the Strategic Includes Patient Empowerment - Terri Conneran, B.Sc. 18 min
- Friday, 4/12 - Session 1: Patient Advocacy
-
Patient Advocacy Groups Can Be a Provider's Partner in Educating Patients on Precision Medicine - Nikki Martin, M.A. 25 min
-
Multi-Disciplinary Research in Li-Fraumeni Syndrome: Spanning the Spectrum from Etiology to Prevention - Payal Khincha, M.B.B.S., M.S.H.S. 22 min
-
Panel Discussion - Patient Advocacy 15 min
- Friday, 4/12 - Session 2: New Approaches to Genomic Care
-
Don't be Dramatic, It's Only Somatic: Building a Somatic to Germline Testing Protocol in Oncology - Dana Farengo-Clark, M.S., CGCsson 29 min
-
Cancer Early Detection and Monitoring via cfDNA and ctDNA - Cristian Tomasetti, Ph.D. 23 min
-
EHRs - Promises, Pitfalls, and Opportunities for Precision Oncology Care and Research - Peter Gabriel, M.D., MSELesson 21 min
-
Panel Discussion: New Approaches to Genomic Care 16 min
- Friday, 4/12 - Session 3: Emerging Research
-
Dissecting Tumor-Microenvironment Interactions and Their Role in the Evolution of Glioblastoma - Frederick Varn, Ph.D. 21 min
-
Molecular Subtypes of Triple-Negative Breast Cancer as Predictors of Response to Platinum-Based Chemotherapy - Francesca Menghi, Ph.D. 18 min
-
Panel Discussion: Emerging Research 23 min
- Keynote Address - COMING SOON
- Saturday, 4/13 - Session 4: New Approaches
-
Overcoming Resistance to Targeted and Immunotherapy - Douglas Johnson, M.D. 21 min
-
Scaling Precision Oncology - In or Out of Reach? - Benedikt Westphalen, M.D. 23 min
-
Panel Discussion: New Approaches 19 min
- Saturday, 4/13 - Session 5: Genomics Across the Continuum from Diagnosis to Treatment
-
Gliomas and Familial Risk- The Gliogene Study - Melissa Bondy, Ph.D. 25 min
-
Novel Strategies for Immune Interception of Cancers in Lynch Syndrome - Jason Willis, M.D., Ph.D. 28 min
-
The Rationale and Challenges of Dual MAPK Plus Immunotherapy - Ryan Sullivan, M.D. 26 min
-
Panel Discussion: Genomics Across the Continuum from Diagnosis to Treatment 22 min
- Saturday, 4/13 - Session 6: Genomic Tumor Boards (GTBs)
-
Workshop: Resistance Mechanisms - Jill Kolesar, Pharm.D., Todd Knepper, Pharm.D., Kathlene Gravelin, M.S., CGC 69 min
- Saturday, 4/13 - Session 7: Genomic Medicine in Cancer - The Big Picture
-
Precision Oncology: Molecular Medicine in Practice - David Thomas, FRACP, Ph.D. 28 min
-
Panel Discussion: Genomic Medicine in Cancer - The Big Picture 29 min
- Evaluation
-
Post-Event Evaluation
- Resources
-
Disclosures
-
References
2024 Maine Cancer Genomics Initiative (MCGI) Forum
Building Bridges Through Genomic Medicine
Welcome to The Maine Cancer Genomics Initiative's (MCGI) Forum: Building Bridges Through Genomic Medicine
During this event, learners will recognize the application of precision oncology programs, clinical trials, and new diagnostic and new technologies in patient care. Learners will identify the advantages and limitations of new technologies and emerging therapeutic approaches and their impacts on patient outcomes. Lastly, learners will recognize the direction of precision oncology and future advancements in patient-centered care.
Who is eligible to take this course?
This course is eligible to registered attendees of the 2024 MCGI Forum.
The content of this event covers:
-
- Patient Advocacy
- New Approaches to Genomic Care
- Emerging Research
- New Approaches
- Genomics Across the Continuum from Diagnosis to Treatment
- Genomic Tumor Board (GTB) Workshop
- Genomic Medicine in Cancer - The Big Picture